Su Jin Lim

2.7k citations
48 papers · 798 indexed · h-index 16
Topics
Pancreatic and Hepatic Oncology Research (9 papers)Prostate Cancer Treatment and Research (9 papers)Cancer Immunotherapy and Biomarkers (8 papers)

In The Last Decade

Su Jin Lim

43 papers receiving 781 citations

Peers

Su Jin Lim
Comparison fields: 5 of 85
  • Oncology 254
  • Pulmonary and Respiratory Medicine 195
  • Ophthalmology 135
  • Surgery 126
  • Molecular Biology 121
Replace Ian K. Anderson with:
Ian K. Anderson United Kingdom
Zhaohao Huang China
Jindra Vrzalová Czechia
Yoshiharu Chijiíwa Japan
Shuhong Wang China
Linda Ye United States
Yansui Li United States
Qing Tian China
Vinodh Kakkassery Germany
Hong Meng China
Su Jin Lim relative to Ian K. Anderson United Kingdom Ian K. Anderson's profile →
Citations per field
00.5×
Ian K. Anderson · 1×
Citations per year

Countries citing papers authored by Su Jin Lim

Since Specialization
Citations

This map shows the geographic impact of Su Jin Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su Jin Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su Jin Lim more than expected).

Fields of papers citing papers by Su Jin Lim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Su Jin Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su Jin Lim. The network helps show where Su Jin Lim may publish in the future.

Co-authorship network of co-authors of Su Jin Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Su Jin Lim. A scholar is included among the top collaborators of Su Jin Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Su Jin Lim. Su Jin Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 41
3 5
4 4
5 5
6 69
7 31
8 58
9 44
10 27
11 37
12 13
13 40
14 14
15 9
16 3
17 4
18 8
19
Infectivity and Pathogenicity of Hepatitis A Virus during an Outbreak in a Communal Living Setting
1
20 44

About Su Jin Lim

Su Jin Lim is a scholar working on Ophthalmology, Oncology and Parasitology, having authored 48 papers that have together received 798 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (9 papers), Prostate Cancer Treatment and Research (9 papers) and Cancer Immunotherapy and Biomarkers (8 papers). The work is most often cited by research in Ophthalmology (135 citations), Endocrine and Autonomic Systems (63 citations) and Oncology (254 citations). Su Jin Lim has collaborated with scholars based in South Korea, United States and Brazil. Frequent co-authors include Oh Woong Kwon, Miin Roh, Hao Wang, Hyun Jik Kim, Kyung Soo Kim, Elizabeth M. Jaffee, Mark Yarchoan, Kyu Eun Lee, Hyun Sang Cho and Nilofer S. Azad. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026